Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: Specific T cell …
N Egri, H Calderón, R Martinez, M Vazquez… - Frontiers in …, 2023 - frontiersin.org
Background Humoral and cellular immune responses are known to be crucial for patients to
recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected …
recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected …
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-Analysis Using GRADE
S Kavikondala, K Haeussler, X Wang… - Infectious Diseases and …, 2024 - Springer
Methods A pairwise meta-analysis of 98 studies reporting comparisons of mRNA-1273 (50
or 100 mcg/dose) and BNT162b2 (30 mcg/dose) in IC adults was performed. Outcomes …
or 100 mcg/dose) and BNT162b2 (30 mcg/dose) in IC adults was performed. Outcomes …
[HTML][HTML] Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors
DJ Epstein, S Otoukesh, Z Shahid… - … and Cellular Therapy, 2024 - Elsevier
Chronic graft-versus-host disease is a frequent and serious complication of allogeneic
hematopoietic cell transplantation and is associated with an increased risk of serious …
hematopoietic cell transplantation and is associated with an increased risk of serious …
[HTML][HTML] Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection among Adult Long-Term Hematopoietic Cell Transplantation Survivors
EC Liang, LE Onstad, P Carpenter, SA Pergam… - … and Cellular Therapy, 2023 - Elsevier
Hematopoietic cell transplantation (HCT) recipients experience significant morbidity and
mortality from coronavirus disease 19 (COVID-19) infection. Data are limited regarding long …
mortality from coronavirus disease 19 (COVID-19) infection. Data are limited regarding long …